Press releases
- Dexcom Publishes Annual Sustainability Report
- Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
- Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
- Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
- Dexcom Announces Upcoming Conference Presentation
- Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results
- Dexcom Launches Dexcom One+ Bringing Powerful, New Diabetes Management Technology to More People
- Dexcom Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call for February 8, 2024 at 4:30 p.m. Eastern Time
More ▼
Key statistics
As of last trade Dexcom Inc (DC4:HAN) traded at 125.54, -3.58% below its 52-week high of 130.20, set on Mar 27, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 125.54 |
---|---|
High | 125.54 |
Low | 125.54 |
Bid | 125.26 |
Offer | 126.18 |
Previous close | 127.68 |
Average volume | 0.00 |
---|---|
Shares outstanding | 385.52m |
Free float | 383.97m |
P/E (TTM) | 104.41 |
Market cap | 51.61bn USD |
EPS (TTM) | 1.28 USD |
Data delayed at least 15 minutes, as of Apr 18 2024 07:07 BST.
More ▼